Institutional Manager · CIK 0001121404
Sanofi
Paris, I0 · File #028-25202
Latest AUM
$310.4M
Positions
8
Top-10 Concentration
100.0%
Filings
5
Portfolio Value Over Time
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | MapLight Therapeutics Inc. | MPLT | +912,041 | +$16.0M | $0 |
| EXITED | Omada Health Inc. | 68170A108 | -524,903 | -$11.6M | $0 |
| EXITED | LAVA Therapeutics N.V. | N51517105 | -1,919,455 | -$3.0M | $0 |
| REDUCE | Inhibrx Biosciences, Inc. | INBX | 0 | $0 | +$52.5M |
| REDUCE | MeiraGTx Holdings plc | MGTX | 0 | $0 | -$3.4M |
| REDUCE | Novavax | NVAX | 0 | $0 | -$13.4M |
| REDUCE | AnaptysBio | ANABV | 0 | $0 | +$14.7M |
| REDUCE | Immuneering Corp | IMRX | 0 | $0 | -$1.1M |
| REDUCE | Eledon | ELDN | 0 | $0 | -$880,178 |
| REDUCE | Q32 Bio Inc. | QTTB | 0 | $0 | +$327,072 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20258 pos · $310.4M
- 13F HOLDINGS REPORTQ/E Sep 20259 pos · $260.4M
- 13F HOLDINGS REPORTQ/E Jun 202510 pos · $175.7M
- 13F HOLDINGS REPORTQ/E Mar 20259 pos · $165.9M
- 13F HOLDINGS REPORTQ/E Dec 20249 pos · $174.4M
Top 8 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | MeiraGTx Holdings plc | MGTX | 12,197,737 | $97.0M | 31.24% |
| 2 | Inhibrx Biosciences, Inc. | INBX | 1,157,926 | $91.5M | 29.47% |
| 3 | Novavax | NVAX | 6,880,481 | $46.2M | 14.90% |
| 4 | AnaptysBio | ANABV | 821,917 | $39.8M | 12.84% |
| 5 | Immuneering Corp | IMRX | 2,708,559 | $17.8M | 5.74% |
| 6 | MapLight Therapeutics Inc. | MPLT | 912,041 | $16.0M | 5.16% |
| 7 | Eledon | ELDN | 814,980 | $1.2M | 0.40% |
| 8 | Q32 Bio Inc. | QTTB | 244,083 | $810,356 | 0.26% |